FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics. What is described is using naltrexone in producing a medicine for treating vesicular rash accompanying herpes zoster or ophthalmic zoster caused by the varicella-zoster virus.
EFFECT: invention provides implementing the above application.
23 cl, 7 tbl, 2 ex
| Title |
Year |
Author |
Number |
| OPIOID ANTAGONIST COMPOUNDS AND USING THEM IN TREATING SCLERODERMIA |
2011 |
- Pisak Ibrakhim Mustafa Iskender
- Pisak Mekhmet
- Selamoglu Mekhmet Levent
- Bingol Semra
|
RU2552290C1 |
| COMBINATIONS OF AGONIST/ANTAGONIST FOR OPIOID |
1998 |
- Kaiko Robert F.
- Koluchchi Robert D.
|
RU2241458C2 |
| COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL DEPENDENCE |
2017 |
- Crystal, Roger
- Agrawal, Arvind
- Maggio, Edward T.
|
RU2767062C2 |
| ANTAGONISTS OF TOL-LIKE RECEPTOR 4 AND USE IN AUTOIMMUNE LIVER DISEASES |
2016 |
- U, Edvin, Essi
- Tszyu, Piter Dzhejes
- Syuj, Mej-Tszi
- Shi, In-Chzhu
|
RU2707560C2 |
| METHOD FOR PREVENTION ABUSE WITH OPIOID- -CONTAINING MEDICINAL FORMULATIONS |
1998 |
|
RU2228180C2 |
| COMPOSITIONS AND METHODS OF TREATING OPIOID OVERDOSE |
2017 |
- Crystal, Roger
- Maggio, Edward T.
|
RU2769397C2 |
| COMPOSITIONS AND METHOD FOR RELIEVING RESPIRATORY DISTRESS CAUSED BY OPIOID OVERDOSE |
2011 |
- Lemson Majkl Dzh.
- Goli Veerajndar
|
RU2541159C2 |
| USE OF NK-1 RECEPTOR ANTAGONIST SERLOPITANT IN PRURITUS |
2014 |
- Zhang Xiaoming
- Schnipper Edward F.
- Perlman Andrew J.
- Larrick James W.
|
RU2666219C2 |
| USE OF OPIOID RECEPTOR ANTAGONIST WITH K-ACTIVITY AND VORTIOXETINE FOR TREATMENT OF DEPRESSIVE DISORDER WITH MELANCHOLIC FEATURES |
2014 |
- Morillo Connie Sanchez
- Smagin Gennady N.
|
RU2679661C1 |
| LAYERED PHARMACEUTICAL COMPOSITIONS |
2007 |
- Makkinni Ehntoni A.
- Tollefson Gehri
- Veber Ehkard
- Soltero Rik
|
RU2452471C2 |
